Inpatient Formulary, Restricted for the prevention and treatment of nausea and vomiting in moderate and highly emetogenic therapy and for refractory cyclic vomiting syndrome.
Restricted to severe acute CVS episode after a trial of 5-HT3 antagonists (ondansetron) and fluids. NSAIDS and triptans should be trialed first for acute CVS episodes in patients with personal or family history of migraine.
Fosaprepitant IV (Emend) is preferred over oral aprepitant, for the first dose for CVS, if patient has IV access.
Aprepitant IV (Aponvie) is Formulary, Restricted for patients undergoing bariatric surgery, for prevention of post-operative nausea and vomiting,
NON-formulary for all other post-operative nausea and vomiting indications. See P & T Committee for more information
Add Formweb to your mobile device
Inpatient Formulary, Restricted for the prevention and treatment of nausea and vomiting in moderate and highly emetogenic therapy and for refractory cyclic vomiting syndrome.
Restricted to severe acute CVS episode after a trial of 5-HT3 antagonists (ondansetron) and fluids. NSAIDS and triptans should be trialed first for acute CVS episodes in patients with personal or family history of migraine.
Fosaprepitant IV (Emend) is preferred over oral aprepitant, for the first dose for CVS, if patient has IV access.
Aprepitant IV (Aponvie) is Formulary, Restricted for patients undergoing bariatric surgery, for prevention of post-operative nausea and vomiting,
NON-formulary for all other post-operative nausea and vomiting indications. See P & T Committee for more information